Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled PackageDuring Manufacturing
January 24, 2024Generic Drug Approvals
February 9, 2024Bromfenac (ophthalmic) - Approved February 2, 2024
Brand names: BromSite, Prolensa, Xibrom, Bromday
Dosage form: ophthalmic solution (0.07%; 0.075%; 0.09%)
Drug class: Ophthalmic anti-inflammatory agents
Bromfenac ophthalmic (for the eyes) is used to treat swelling and pain caused by cataract surgery. Bromfenac is a non-steroidal anti-inflammatory drug (NSAID).